AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Texas Instruments
TXN
|
+$792M |
| 2 |
Home Depot
HD
|
+$649M |
| 3 |
Netflix
NFLX
|
+$612M |
| 4 |
West Pharmaceutical
WST
|
+$528M |
| 5 |
Zoetis
ZTS
|
+$444M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$1.27B |
| 2 |
MSCI
MSCI
|
+$807M |
| 3 |
Fortinet
FTNT
|
+$765M |
| 4 |
Nike
NKE
|
+$707M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$534M |
Sector Composition
| 1 | Technology | 29.82% |
| 2 | Healthcare | 15.99% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.41% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
W.W. Grainger
GWW
$47.5B
| $65.8M | 0.02% |
72,956
-296
| -0.4% | -$267K |
|
527
Viking Therapeutics
VKTX
$2.91B
| $65.8M | 0.02% |
1,241,125
-319,753
| -20% | -$17M |
|
528
Autodesk
ADSK
$69B
| $65.7M | 0.02% |
265,470
-1,366,283
| -84% | -$338M |
|
529
Quest Diagnostics
DGX
$20.1B
| $65.6M | 0.02% |
479,598
+20,724
| +5% | +$2.84M |
|
530
BrightSpring Health Services
BTSG
$4.97B
| $65.6M | 0.02% |
5,778,781
+194,891
| +3% | +$2.21M |
|
531
Aon
AON
$78.1B
| $65.5M | 0.02% |
223,003
+3,835
| +2% | +$1.13M |
|
|
PDS
532
Precision Drilling
PDS
$759M
| $65.4M | 0.02% |
+1,100
| New | +$65.4M |
|
533
Biogen
BIIB
$20.9B
| $65.2M | 0.02% |
281,289
+79,398
| +39% | +$18.4M |
|
534
TPG
TPG
$8.85B
| $65.2M | 0.02% |
1,572,430
-105,844
| -6% | -$4.39M |
|
535
Ascendis Pharma
ASND
$12B
| $64.8M | 0.02% |
475,001
+1,248
| +0.3% | +$170K |
|
536
Core & Main
CNM
$9.21B
| $64.7M | 0.02% |
1,322,994
-297,772
| -18% | -$14.6M |
|
537
Ameriprise Financial
AMP
$46.4B
| $64.7M | 0.02% |
151,369
-952
| -0.6% | -$407K |
|
538
Arthur J. Gallagher & Co
AJG
$75.2B
| $64.3M | 0.02% |
247,882
-1,963
| -0.8% | -$509K |
|
539
Rubrik
RBRK
$15.6B
| $64.3M | 0.02% |
+2,096,112
| New | +$64.3M |
|
540
Ultragenyx Pharmaceutical
RARE
$3.02B
| $62.8M | 0.02% |
1,527,875
+45,404
| +3% | +$1.87M |
|
541
Bank of New York Mellon
BK
$73.3B
| $62.7M | 0.02% |
1,047,124
-42,621
| -4% | -$2.55M |
|
542
BridgeBio Pharma
BBIO
$10.1B
| $62.1M | 0.02% |
2,452,404
-391,895
| -14% | -$9.93M |
|
543
UDR
UDR
$12.7B
| $62.1M | 0.02% |
1,508,905
+964,784
| +177% | +$39.7M |
|
544
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.96B
| $62M | 0.02% |
861,360
-113,464
| -12% | -$8.17M |
|
545
PJT Partners
PJT
$4.37B
| $62M | 0.02% |
574,441
-59,570
| -9% | -$6.43M |
|
546
Hilton Worldwide
HLT
$64.2B
| $61.8M | 0.02% |
283,095
-9,698
| -3% | -$2.12M |
|
547
Williams Companies
WMB
$71.8B
| $61.7M | 0.02% |
1,451,177
-44,721
| -3% | -$1.9M |
|
548
Marriott International Class A Common Stock
MAR
$71.2B
| $61.6M | 0.02% |
254,624
-9,829
| -4% | -$2.38M |
|
|
CERE
549
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $61.1M | 0.02% |
1,494,341
+321,454
| +27% | +$13.1M |
|
|
SUM
550
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $60.6M | 0.02% |
1,655,960
-426,756
| -20% | -$15.6M |
|